These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 33592945)

  • 21. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite.
    Lehane AM; Saliba KJ
    BMC Res Notes; 2008 Jun; 1():26. PubMed ID: 18710482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite.
    Kannan D; Yadav N; Ahmad S; Namdev P; Bhattacharjee S; Lochab B; Singh S
    EBioMedicine; 2019 Jul; 45():261-277. PubMed ID: 31255656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites.
    Reiling SJ; Rohrbach P
    Malar J; 2019 Oct; 18(1):342. PubMed ID: 31590674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viability Screen of LOPAC
    Tong JX; Ang SEL; Tan EHN; Tan KSW
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
    Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
    Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic Analysis of Chloroquine-Sensitive and Chloroquine-Resistant Strains of Plasmodium falciparum: Toward Malaria Diagnostics and Therapeutics for Global Health.
    Antony HA; Pathak V; Parija SC; Ghosh K; Bhattacherjee A
    OMICS; 2016 Jul; 20(7):424-32. PubMed ID: 27428254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH.
    Bennett TN; Kosar AD; Ursos LM; Dzekunov S; Singh Sidhu AB; Fidock DA; Roepe PD
    Mol Biochem Parasitol; 2004 Jan; 133(1):99-114. PubMed ID: 14668017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab7 of Plasmodium falciparum is involved in its retromer complex assembly near the digestive vacuole.
    Siddiqui AA; Saha D; Iqbal MS; Saha SJ; Sarkar S; Banerjee C; Nag S; Mazumder S; De R; Pramanik S; Debsharma S; Bandyopadhyay U
    Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129656. PubMed ID: 32512169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds.
    Teklemichael AA; Mizukami S; Toume K; Mosaddeque F; Kamel MG; Kaneko O; Komatsu K; Karbwang J; Huy NT; Hirayama K
    Malar J; 2020 Jun; 19(1):204. PubMed ID: 32513250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum.
    Abu Bakar N; Klonis N; Hanssen E; Chan C; Tilley L
    J Cell Sci; 2010 Feb; 123(Pt 3):441-50. PubMed ID: 20067995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cure with cisplatin (II) or murine malaria infection and in vitro inhibition of a chloroquine-resistant Plasmodium falciparum isolate.
    Nair L; Bhasin VK
    Jpn J Med Sci Biol; 1994; 47(5-6):241-52. PubMed ID: 7739147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of complement immune response on artemisinin-based combination therapy in a population from malaria endemic region of Western Kenya.
    Wanjala CNL; Bergmann-Leitner E; Akala HM; Odhiambo G; Ogutu BR; Andagalu B; Kamau E; Ochiel D
    Malar J; 2020 Apr; 19(1):168. PubMed ID: 32349765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
    Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
    Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stilbene-chalcone hybrids: design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis.
    Sharma N; Mohanakrishnan D; Shard A; Sharma A; Saima ; Sinha AK; Sahal D
    J Med Chem; 2012 Jan; 55(1):297-311. PubMed ID: 22098429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine.
    Brice BK; William Y; Lacina O; Félix Y; Hugues A; Léonardo B; André M; Joseph D
    Tanzan J Health Res; 2010 Jan; 12(1):73-9. PubMed ID: 20737832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.